Search
Valiltramiprosate
go.drugbank.com/drugs/DB19191InvestigationalValiltramiprosate is under investigation in clinical trial NCT06304883 (Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects).
Categories: Amino Acids, Peptides, and ProteinsPF-06273340
go.drugbank.com/drugs/DB12269Investigationalof Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)). … Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects
ISB 1442
go.drugbank.com/drugs/DB18475InvestigationalISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47
Dilanubicel
go.drugbank.com/drugs/DB18722InvestigationalDilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.
Bacillus amyloliquefaciens
go.drugbank.com/drugs/DB15667InvestigationalMixtures: Lamwave antimicrobial hand sanitizers gel, Lamwave antimicrobial hand sanitizers gelFlurbiprofen axetil
go.drugbank.com/drugs/DB14938InvestigationalFlurbiprofen axetil is under investigation in clinical trial NCT02043366 (Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients).
MBP-091
go.drugbank.com/drugs/DB17741ExperimentalMBP-091 is a monoclonal antibody being investigated for the treatment of Marburg virus disease (MVD) caused by infection with Marburg virus (MARV).[L46212]
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide
go.drugbank.com/drugs/DB06945ExperimentalThis substance is known to target a disintegrin and metalloproteinase with thrombospondin motifs 5. … These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups.
Rheinanthrone
go.drugbank.com/drugs/DB13175ExperimentalIt is commonly produced by plants of the Rheum species [L772].
VXA-CoV2-1
go.drugbank.com/drugs/DB16433Investigationalresponses to both vaccine antigens of the SARS-CoV-2 nucleocapsid and spike proteins[L30498]. … VXA-CoV2-1 is a non-replicating adenoviral vector-based oral tableted vaccine candidate that expresses a SARS-CoV-2 antigen and dsRNA adjuvant[L30493].